DNA Methylation of the Human Placenta pp. 333-7
The human placenta, in addition to other neonatal tissues and whole blood, is commonly sampled for the study of epigenetic modifications. Hogg et al. now present general recommendations for the reporting of DNA methylation in biological samples, with specific focus on the placenta.
ZAC1 Methylation and Infant Growth pp. 338-45
The ZAC1 gene is part of a network of co-regulated imprinted genes involved in the control of embryonic growth. Loss of methylation at the ZAC1 DMR is associated with transient neonatal diabetes mellitus, a developmental disorder involving growth retardation and diabetes in the first weeks of post-natal life. Azzi et al. now assessed whether the degree of methylation of the ZAC1 DMR in leukocytes DNA extracted from cord blood is associated with fetal, birth and post-natal growth.
DCLK1 is an Epigenetic Biomarker
for Colorectal Cancer pp. 346-50 DCLK1 expression was recently identified as an intestinal cancer stem cellspecific biomarker in mouse models, implicating a potential role for targeting the DCLK1-postive cancer cells as a treatment for colorectal cancer. Now, Vedeld et al. show that DCLK1 is also a colorectal cancer biomarker for early detection, and discuss the clinical implications regarding the previously proposed therapy toward DCLK1-positive cancer cells.
New DMRs in Maternal and
Paternal UPD for Chromosome 7 pp. 351-65
Imprinted genes are expressed only from the maternal or paternal allele and their normal balance can be disrupted when two copies of a chromosome from one parent and no copies from the other parent are inherited (a phenomenon called uniparental disomy or UPD). Maternal UPD for chromosome 7 results in Silver-Russell syndrome (SRS), which presents typical features and growth retardation, even though no gene has been conclusively implicated in SRS. Now, Hannula-Jouppi et al. present the first comprehensive map of parent-of-origin specific DMRs on human chromosome 7, suggesting many new imprinted sites.
DNA Methylation in Chronic Kidney Disease pp. 366-76
Smyth et al. report the largest, most comprehensive, genome-wide quantitative evaluation of DNA methylation for association with chronic kidney disease (CKD). Investigating how these methylation sites influence the development of CKD will help identify epigenetic therapies that might be clinically useful for the treatment of this disease.
AHRR Methylation and Maternal
Smoking during Pregnancy pp. 377-86
While in utero environmental/stochastic factors are known to influence DNA methylation profile at birth, it has been difficult to assign specific examples of epigenetic variation to specific environmental exposures. Novakovic et al. now confirm the previous association between maternal smoking and AHRR methylation in neonatal blood. In addition, their study expands the region of AHRR methylation altered in response to maternal smoking during pregnancy and reveals the tissuespecific nature of epigenetic responses to environmental exposures in utero.
Effect of Azacitidine and Decitabine on IL3
in a Model of AML pp. 387-95
Human acute myeloid leukemia (AML) is characterized by a block in maturation caused by genetic and epigenetic alterations. Buchi et al. now studied the effects of low concentrations of DNMT inhibitors 5-azacitidine and decitabine on apoptosis and on chromatin remodeling in an AML1/ETO inducible model of human AML. The authors observed that low concentrations of DNMT inhibitors induced a loss of H3K27me3 and gain of acetylated histone H4 at the IL3 promoter exclusively in AML1/ETO-positive cells, which was associated with transcriptional reactivation of the IL3 gene.
Impact of Folic Acid Fortification on Global DNA Methylation pp. 396-403
Bae et al. investigated the impact of folic acid fortification of the US food supply on leukocyte global DNA methylation and the relationship between DNA methylation, red blood cell (RBC) folate, and other one-carbon biomarkers among postmenopausal women. Their data suggest that, during folic acid fortification, higher RBC folate status is associated with a reduction in leukocyte global DNA methylation among postmenopausal women.
In addition, the relationship between onecarbon biomarkers and global DNA methylation is dependent on folate availability.
LINE1 Methylation and Increased Bladder Cancer Risk pp. 404-15
Global methylation in blood DNA has been associated with bladder cancer risk in case-control studies, but has not been examined prospectively. Andreotti et al. examined the association between LINE1 total percent 5-methylcytosine and bladder cancer risk using pre-diagnostic blood DNA from different cohorts. Their findings suggest that higher global methylation levels prior to diagnosis may increase bladder cancer risk, particularly among male smokers.
Sex-related Differences in the SOX9 Regulatory Region pp. 416-27
Duplications of the RevSex element, located 0.5 Mb upstream of SOX9, cause XX-disorder of sex development (DSD); deletions of the same element cause XY-DSD. Lybaek et al. explored how a 148 Kb RevSex duplication could have turned on gonadal SOX9 expression in the absence of SRY in an XX-male by examining the chromatin landscape in primary skin fibroblast cultures from the index, his RevSex duplication-carrier father and controls. Their results suggest that the RevSex duplication could operate by inducing long-range epigenetic changes. Furthermore, the differences in chromatin state maps between males and females suggest that the Y chromosome or X chromosome dosage may affect chromatin conformation.
A Colorectal Cancer DNA Methylation Marker Panel pp. 428-36
Genes with altered DNA methylation can be used as biomarkers for cancer detection and assessment of prognosis. Now, Bethge et al. analyzed the methylation status of a colorectal cancer biomarker panel (CNRIP1, FBN1, INA,  MAL, SNCA, and SPG20) in 97 cancer cell lines, derived from 17 different cancer types. Their results suggest that SNCA and SPG20 methylation might be suitable for early detection and monitoring of NHL. Furthermore, CNRIP1 could potentially be used as a prognostic factor in DLBCL.
Prenatal Stress in Rats and Bdnf Expression pp. 437-47
Exposure to stress during gestation increases the risk of the offspring to develop mood disorders. Brain-derived neurotrophic factor (Bdnf) plays a critical role during neuronal development and is therefore a prime candidate to modulate neuronal signaling in adult offspring of rat dams that were stressed during gestation. Now, Boersma et al. tested the hypothesis that alterations in Bdnf expression in prenatally stressed offspring are mediated by changes in DNA methylation in exons IV and VI of the Bdnf gene.
Air Pollution and Gene-specific Methylation pp. 448-58
The mechanisms by which air pollution has multiple systemic effects in humans are not fully elucidated, but appear to include inflammation and thrombosis. Bind et al. now examined whether concentrations of ozone and components of fine particle mass are associated with changes in methylation on tissue factor (F3), interferon gamma (IFN-γ), interleukin 6 (IL-6 ), toll-like receptor 2 (TLR-2), and intercellular adhesion molecule 1 (ICAM-1). The authors investigated associations between air pollution exposure and gene-specific methylation in elderly men.
Epigenetic Deregulation in Pediatric ALL pp. 459-7
Genome-wide DNA methylation profiles are commonly altered in pediatric acute lymphoblastic leukemia (ALL); however, recent observations highlight that a large portion of malignancy-associated DNA methylation alterations are not accompanied by related gene expression changes. Now, Chatterton et al. report specific DNA methylation alterations with concurrent gene expression changes within individual ALL subtypes.
Meeting Report pp. 468-75
A summary of the Barcelona Conference on Epigenetics and Cancer "Challenges, opportunities and perspectives" held on November 21-22, 2013 is presented.
